Design of New Derivatives of Dimedone Molecules Using QSAR and Docking Molecular

Design of New Derivatives of Dimedone Molecules Using QSAR and Docking Molecular

In this work, we investigated the quantitative relationship between biological activity against non-small cell lung cancer (NSCLC) and the molecular structure of a series of 38 cyclohexane-1,3-dione-dimidone derivatives. For this purpose, molecular descriptors calculated by DFT-B3LYP/6-31G, topologi...

Full description

Bibliographic Details
Main Authors:	Khaoula Mkhayar, Ossama Daoui, Rachid Haloui, Souad Elkhattabi, Samir Chtita
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	Medical Sciences Forum
Subjects:	QSAR ADMET molecular docking NSCLC C-met
Online Access:	https://www.mdpi.com/2673-9992/14/1/106

Similar Items

Design of novel small molecules derived from styrylpyridine as potent HDAC1 inhibitors for the treatment of gastric cancer using 3D-QSAR, drug similarity, ADMET prediction, molecular docking, and molecular dynamics studies
by: Rachid Haloui, et al.
Published: (2024-03-01)

Design of new molecules against cervical cancer using DFT, theoretical spectroscopy, 2D/3D-QSAR, molecular docking, pharmacophore and ADMET investigations
by: Said El Rhabori, et al.
Published: (2024-02-01)

Combined 3D-QSAR and Molecular Docking Analysis of Thienopyrimidine Derivatives as Staphylococcus aureus Inhibitors
by: Mebarka Ouassaf, et al.
Published: (2021-06-01)

Ligand-Based Design of Novel Quinoline Derivatives as Potential Anticancer Agents: An In-Silico Virtual Screening Approach
by: Khaoula Mkhayar, et al.
Published: (2024-01-01)

Integrative Approach for Designing Novel Triazole Derivatives as α-Glucosidase Inhibitors: QSAR, Molecular Docking, ADMET, and Molecular Dynamics Investigations
by: Oussama Abchir, et al.
Published: (2024-02-01)

Design, 3D-QSAR, molecular docking, ADMET, molecular dynamics and MM-PBSA simulations for new anti-breast cancer agents
by: Said El Rhabori, et al.
Published: (2024-06-01)

Design of a new potent Alzheimer's disease inhibitor based on QSAR, molecular docking and molecular dynamics investigations
by: Meriem Khedraoui, et al.
Published: (2023-12-01)

Exploration of Cannabis constituents as potential candidates against diabetes mellitus disease using molecular docking, dynamics simulations and ADMET investigations
by: Oussama Abchir, et al.
Published: (2023-09-01)

Combined 3D-QSAR, molecular docking, ADMET, and drug-likeness scoring of novel diaminodihydrotriazines as potential antimalarial agents
by: Nedjla Khelfa, et al.
Published: (2024-06-01)

Docking and QSAR of Aminothioureas at the SARS-CoV-2 S-Protein–Human ACE2 Receptor Interface
by: Wojciech Płonka, et al.
Published: (2020-10-01)

Computational studies of pyrimidine derivatives as inhibitors of human σ1 receptor using 3D-QSAR analysis, molecular docking, ADMET properties and DFT investigation
by: Maroua Fattouche, et al.
Published: (2024-06-01)

QSAR ANALYSIS USING SEMI-EMPIRICAL AM1 METHOD, MOLECULAR DOCKING, AND ADMET STUDIES OF CHALCONE DERIVATIVES AS ANTIMALARIAL COMPOUNDS
by: Muhammad Akbar S Kurniawan, et al.
Published: (2023-12-01)

Potent VEGFR-2 inhibitors for resistant breast cancer: a comprehensive 3D-QSAR, ADMET, molecular docking and MMPBSA calculation on triazolopyrazine derivatives
by: Soukayna Baammi, et al.
Published: (2023-11-01)

QSAR modelling, molecular docking, molecular dynamic and ADMET prediction of pyrrolopyrimidine derivatives as novel Bruton’s tyrosine kinase (BTK) inhibitors
by: Mourad Aloui, et al.
Published: (2024-01-01)

Combined computational approaches for developing new anti-Alzheimer drug candidates: 3D-QSAR, molecular docking and molecular dynamics studies of liquiritigenin derivatives
by: Hassan Nour, et al.
Published: (2022-12-01)

QSAR, ADMET In Silico Pharmacokinetics, Molecular Docking and Molecular Dynamics Studies of Novel Bicyclo (Aryl Methyl) Benzamides as Potent GlyT1 Inhibitors for the Treatment of Schizophrenia
by: Mohamed El fadili, et al.
Published: (2022-05-01)

2D-QSAR, Docking, Molecular dynamics simulations with the MM/GBSA approaches against Grave's disease and PTPN22
by: Emmanuel Israel Edache, et al.
Published: (2023-08-01)

Quantitative Structure-Activity relationship, Molecular Docking and ADMET Screening of Tetrahydroquinoline Derivatives as Anti-Small Cell Lung Cancer Agents
by: Ehimen Annastasia Erazua, et al.
Published: (2023-01-01)

The anti-SARS-CoV-2 activity of novel 9, 10-dihydrophenanthrene derivatives: an insight into molecular docking, ADMET analysis, and molecular dynamics simulation
by: Imane Yamari, et al.
Published: (2023-09-01)

Computer-Aided Strategy on 5-(Substituted benzylidene) Thiazolidine-2,4-Diones to Develop New and Potent PTP1B Inhibitors: QSAR Modeling, Molecular Docking, Molecular Dynamics, PASS Predictions, and DFT Investigations
by: Nour-El Houda Derki, et al.
Published: (2024-02-01)

Computational assessment of the reactivity and pharmaceutical potential of novel triazole derivatives: An approach combining DFT calculations, molecular dynamics simulations, and molecular docking
by: Kamal Tabti, et al.
Published: (2024-01-01)

Catastrophic Collision Between Obesity and COVID-19 Have Evoked the Computational Chemistry for Research in Silico Design of New CaMKKII Inhibitors Against Obesity by Using 3D-QSAR, Molecular Docking, and ADMET
by: Halima Hajji, et al.
Published: (2021-10-01)

3D-QSAR, ADMET and Docking Studies for Design New 5,5-Diphenylimidazolidine-2,4-dione Derivatives Agents Against Cervical Cancer
by: Reda EL-Mernissi, et al.
Published: (2022-04-01)

In Silico Exploration of Aryl Halides Analogues as CheckpointKinase 1 Inhibitors by Using 3D QSAR, Molecular Docking Study,and ADMET Screening
by: Adib Ghaleb, et al.
Published: (2019-02-01)

Design of new α-glucosidase inhibitors through a combination of 3D-QSAR, ADMET screening, molecular docking, molecular dynamics simulations and quantum studies
by: Ayoub Khaldan, et al.
Published: (2024-03-01)

Comparison of the binding energies of approved mpox drugs and phytochemicals through molecular docking, molecular dynamics simulation, and ADMET studies: An in silico approach
by: Ranjan K. Mohapatra, et al.
Published: (2023-09-01)

Prediction of potential inhibitors of SARS-CoV-2 using 3D-QSAR, molecular docking modeling and ADMET properties
by: Ayoub Khaldan, et al.
Published: (2021-03-01)

2D-QSAR, molecular docking, drug-likeness, and ADMET/pharmacokinetic predictions of some non-small cell lung cancer therapeutic agents
by: M.T. Ibrahim, PhD, et al.
Published: (2023-04-01)

Quantitative Structure-Activity Relationship, Structure-based Design, and ADMET studies of pyrimethamine and cycloguanil analogs inhibitors of Plasmodium falciparum dihydrofolate reductase-thymidylate synthase (PfDHFR-TS).
by: Zakari Ya'u Ibrahim, et al.
Published: (2022-12-01)

Modified coptisine derivatives as an inhibitor against pathogenic Rhizomucor miehei, Mycolicibacterium smegmatis (Black Fungus), Monkeypox, and Marburg virus by molecular docking and molecular dynamics simulation-based drug design approach
by: Shopnil Akash, et al.
Published: (2023-04-01)

Quinazoline analogues as cytotoxic agents; QSAR, docking, and in silico studies
by: Leila Emami, et al.
Published: (2021-01-01)

Virtual screening and pharmacokinetics analysis of inhibitors against tuberculosis: Structure and ligand-based approach
by: Stephen E. Abechi, et al.
Published: (2024-03-01)

Molecular docking, drug-likeness and DFT study of some modified tetrahydrocurcumins as potential anticancer agents
by: Ahmed Mahal, et al.
Published: (2024-01-01)

Pharmacokinetic profiling of quinazoline-4(3H)-one analogs as EGFR inhibitors: 3D-QSAR modeling, molecular docking studies and the design of therapeutic agents
by: Sagiru Hamza Abdullahi, PhD, et al.
Published: (2023-10-01)

Lipoxygenase Inhibition Activity of Coumarin Derivatives—QSAR and Molecular Docking Study
by: Melita Lončarić, et al.
Published: (2020-07-01)

Benzoquinoline Derivatives: A Straightforward and Efficient Route to Antibacterial and Antifungal Agents
by: Vasilichia Antoci, et al.
Published: (2021-04-01)

N-Phenyl Ureidobenzenesulfonate derivatives as novel anticancer agents: QSAR and Molecular docking studies
by: Masood Fereidoonnezhad, et al.
Published: (2017-05-01)

N-Phenyl Ureidobenzenesulfonate derivatives as novel anticancer agents: QSAR and Molecular docking studies
by: Masood Fereidoonnezhad, et al.
Published: (2017-06-01)

QSAR modeling, molecular docking and molecular dynamic simulation of phosphorus-substituted quinoline derivatives as topoisomerase I inhibitors
by: Mouad Lahyaoui, et al.
Published: (2023-06-01)

QSAR, molecular docking, and design of novel 4-(N,N-diarylmethyl amines) Furan-2(5H)-one derivatives as insecticides against Aphis craccivora
by: Yusuf Isyaku, et al.
Published: (2020-03-01)